ipm: Indian pharma market grew 12.1% in August, AWACS report

Indian pharmaceutical market (IPM) grew 12.1% in worth and 4.8% in volumes, within the month of August on again of sturdy progress throughout all of the remedy areas, based on market analysis agency AWACS.

IPM noticed gross sales of Rs 16,239 crore throughout August.

The wholesale worth index (WPI) inflation linked worth hike allowed by the federal government has helped the pharma trade to extend by 10% on medicine below worth management, together with monsoon linked infectious ailments.

The quickest rising classes are cardiac which grew at 13%, anti-infectives – 13% and gastrointestinal – 12%. Anti-diabetes and nutritional vitamins grew 9% respectively.

Augmentin of GSK, Glycomet of USV and Mixtard of Abbott, stay top-3 promoting manufacturers in India.